RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment

Peng Kong1, Xu Wang1,2, Ya-Kun Gao1

  • 1Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Key Laboratory of Medical Biotechnology of Hebei Province, Hebei Medical University, Shijiazhuang, China.

Biology Direct
|November 21, 2023
PubMed
Abstract

Insights

Regulator of G protein signaling 5 (RGS5) normally prevents vascular inflammation but promotes it in breast tumors. Tumor environments alter RGS5 function, aiding cancer progression and metastasis.

Area of Science:

  • Vascular Biology
  • Oncology
  • Cell Signaling

Background:

  • Regulator of G protein signaling 5 (RGS5) is highly expressed in vascular smooth muscle cells (VSMCs) and pericytes.
  • RGS5 negatively regulates G protein-coupled receptor (GPCR) signaling and influences VSMC phenotype and tumor vascular remodeling.
  • Its precise role in normal versus tumor vascular remodeling remains controversial.

Purpose of the Study:

  • To investigate the functional significance of RGS5 in vascular inflammation and remodeling.
  • To determine RGS5 expression in breast cancer tissues and its role in tumor vascularization.
  • To elucidate how breast cancer cell-conditioned media affects VSMC phenotype.

Main Methods:

  • Utilized RGS5 knockout mice and adeno-associated virus (AAV)-mediated in vivo RGS5 manipulation in VSMCs.
  • Assessed RGS5 expression in triple-negative breast cancer (TNBC) and non-TNBC tissues via immunofluorescence and immunohistochemistry.
  • Evaluated VSMC pro-inflammatory phenotype using phagocytic activity assays, adhesion assays, and Western blot analysis after exposure to breast cancer cell-conditioned media (BC-CM).

Main Results:

  • RGS5 deficiency exacerbated VSMC accumulation and pyroptosis, leading to vascular remodeling, which was reversed by RGS5 overexpression.
  • In breast cancer, RGS5 expression was elevated in TNBC tissues and tumor vasculature, correlating with increased vascular networks.
  • BC-CM induced a pro-inflammatory and adhesive VSMC phenotype, with evidence of tumor-derived RGS5 transfer to VSMCs.

Conclusions:

  • The tumor microenvironment reprograms RGS5 from an anti-inflammatory to a pro-inflammatory mediator.
  • Tumor-induced RGS5 promotes a pro-inflammatory VSMC phenotype that supports tumor metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K